ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,947Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 1121

$620K Total Retail Price of All Prescriptions

Rank: 272 out of 1121

658 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 658 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 658 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 15,604 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 1,128 1,027 1 1
LISINOPRIL 747 665 2 4
OMEPRAZOLE 518 462 3 6
AMLODIPINE BESYLATE 493 485 4 5
LEVOTHYROXINE SODIUM 489 468 5 2
HYDROCODONE-ACETAMINOPHEN 474 407 S3 6 3
FUROSEMIDE 447 404 7 7
METFORMIN HCL 424 398 8 8
METOPROLOL TARTRATE 410 397 9 9
ATENOLOL 353 338 10 16
HYDROCHLOROTHIAZIDE 351 345 11 10
LOVASTATIN 326 302 12 26
LOSARTAN POTASSIUM 283 258 13 17
WARFARIN SODIUM 251 245 14 11
GABAPENTIN 233 197 15 13
ALLOPURINOL 232 226 16 30
PANTOPRAZOLE SODIUM 203 175 17 29
METOPROLOL SUCCINATE 200 187 18 23
PRAVASTATIN SODIUM 196 162 19 14
ATORVASTATIN CALCIUM 188 172 20 15
AZITHROMYCIN 187 170 21 44
ALENDRONATE SODIUM 187 187 21 37
ENALAPRIL MALEATE 179 179 23 73
CITALOPRAM HBR 169 159 24 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 167 164 25 31
MELOXICAM 166 146 26 22
ZOLPIDEM TARTRATE 164 139 27 19
SERTRALINE HCL 161 152 28 21
GLIMEPIRIDE 156 154 29 34
TRAMADOL HCL 147 116 30 25
DIGOXIN 143 143 31 59
FLUTICASONE PROPIONATE 137 127 32 36
CARVEDILOL 128 128 33 20
PREDNISONE 127 112 34 43
TRIAMTERENE-HCTZ 123 123 35 38
POTASSIUM CHLORIDE 120 118 36 12
INDAPAMIDE 115 115 37 138
AMITRIPTYLINE HCL 109 107 R 38 61
CLOPIDOGREL 105 94 39 27
VERAPAMIL ER 100 100 40 89
NEXIUM 99 89 41 24
LOSARTAN-HYDROCHLOROTHIAZIDE 98 98 42 46
INSULIN SYRINGE 93 92 43 77
PLAVIX 91 78 44 42
ISOSORBIDE MONONITRATE ER 89 87 45 62
PAROXETINE HCL 88 85 46 58
TAMSULOSIN HCL 87 79 47 32
RANITIDINE HCL 85 76 48 33
PREMARIN 85 85 R 48 96
TIZANIDINE HCL 82 69 50 124
TRAZODONE HCL 81 69 51 40
GLYBURIDE 79 79 R 52 51
CIPROFLOXACIN HCL 79 76 52 57
GEMFIBROZIL 78 64 54 88
BISOPROLOL-HYDROCHLOROTHIAZIDE 78 78 54 179
ESTRADIOL 78 66 R 54 95
LANTUS 76 71 57 52
MIRTAZAPINE 73 65 58 56
ACETAMINOPHEN-CODEINE 71 71 S3 59 161
VENTOLIN HFA 68 65 60 92
KLOR-CON 8 67 59 61 212
METFORMIN HCL ER 66 66 62 47
METOCLOPRAMIDE HCL 62 50 63 120
VENLAFAXINE HCL ER 61 37 64 113
DILTIAZEM ER 61 57 64 105
FLUOXETINE HCL 60 38 66 60
FAMOTIDINE 59 54 67 63
MECLIZINE HCL 59 58 67 115
SPIRONOLACTONE 58 58 69 54
TERAZOSIN HCL 56 44 70 130
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 55 70 108
CLONIDINE HCL 56 56 70 39
CYMBALTA 55 32 73 50
NIFEDIAC CC 53 53 74 200
ADVAIR DISKUS 52 48 75 64
DONEPEZIL HCL 51 46 76 35
NIFEDIPINE ER 51 48 76 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.